Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Survivin is regulated by interleukin‐4 in colon cancer stem cells
Anna Barbara Di Stefano, Flora Iovino, Ylenia Lombardo, et al.
Journal of Cellular Physiology (2010) Vol. 225, Iss. 2, pp. 555-561
Closed Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

Natural killer cells and other innate lymphoid cells in cancer
Laura Chiossone, Pierre‐Yves Dumas, Margaux Vienne, et al.
Nature reviews. Immunology (2018) Vol. 18, Iss. 11, pp. 671-688
Closed Access | Times Cited: 851
Comparative Proteomics of Colon Cancer Stem Cells and Differentiated Tumor Cells Identifies BIRC6 as a Potential Therapeutic Target
Winan J. van Houdt, Benjamin Emmink, TV Pham, et al.
Molecular & Cellular Proteomics (2011) Vol. 10, Iss. 12, pp. M111.011353-M111.011353
Open Access | Times Cited: 121
Emerging Importance of Survivin in Stem Cells and Cancer: the Development of New Cancer Therapeutics
Neerada Meenakshi Warrier, Prasoon Agarwal, Praveen Kumar
Stem Cell Reviews and Reports (2020) Vol. 16, Iss. 5, pp. 828-852
Open Access | Times Cited: 69
Possible Roles of Interleukin-4 and -13 and Their Receptors in Gastric and Colon Cancer
Xujun Song, Benno Traub, Jingwei Shi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 727-727
Open Access | Times Cited: 59
Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs
Qi Zhao, Hong Zong, Pingping Zhu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Cisplatin-eugenol Pt(IV) prodrugs target colon cancer stem cells: A novel strategy for enhanced anticancer efficacy
Vojtěch Novohradský, Tomer Babu, Hana Kostrhunová, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117854-117854
Closed Access | Times Cited: 1
Oct-4 is required for an antiapoptotic behavior of chemoresistant colorectal cancer cells enriched for cancer stem cells: Effects associated with STAT3/Survivin
Kunming Wen, Zhongxue Fu, Xingye Wu, et al.
Cancer Letters (2013) Vol. 333, Iss. 1, pp. 56-65
Closed Access | Times Cited: 87
Integrating Immunologic Signaling Networks: The JAK/STAT Pathway in Colitis and Colitis-Associated Cancer
Sebastian Zundler, Markus F. Neurath
Vaccines (2016) Vol. 4, Iss. 1, pp. 5-5
Open Access | Times Cited: 83
Combined CD133/CD44 Expression as a Prognostic Indicator of Disease-Free Survival in Patients With Colorectal Cancer
Gennaro Galizia, Marica Gemei, Luigi Del Vecchio, et al.
Archives of Surgery (2012) Vol. 147, Iss. 1, pp. 18-18
Open Access | Times Cited: 82
Tumor-Initiating Cells: a criTICal review of isolation approaches and new challenges in targeting strategies
Komal Qureshi-Baig, Pit Ullmann, Serge Haan, et al.
Molecular Cancer (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 77
E2F1/SP3/STAT6 axis is required for IL-4-induced epithelial-mesenchymal transition of colorectal cancer cells
Jiaoe Chen, Chaoju Gong, Huiqin Mao, et al.
International Journal of Oncology (2018)
Open Access | Times Cited: 75
Oncogenic STAT Transcription Factors as Targets for Cancer Therapy: Innovative Strategies and Clinical Translation
Weiyuan Wang, Melanie Cristina Lopez McDonald, Rajashree Hariprasad, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1387-1387
Open Access | Times Cited: 6
Cytokine disbalance in common human cancers
Zoran Čulig
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2010) Vol. 1813, Iss. 2, pp. 308-314
Closed Access | Times Cited: 86
IL‐4 induces proliferation in prostate cancer PC3 cells under nutrient‐depletion stress through the activation of the JNK‐pathway and survivin up‐regulation
Hernan Roca, Matthew Craig, Ying Chi, et al.
Journal of Cellular Biochemistry (2011) Vol. 113, Iss. 5, pp. 1569-1580
Open Access | Times Cited: 72
N-3 PUFAs have antiproliferative and apoptotic effects on human colorectal cancer stem-like cells in vitro
Ting Yang, Fang Shi, Haixia Zhang, et al.
The Journal of Nutritional Biochemistry (2012) Vol. 24, Iss. 5, pp. 744-753
Closed Access | Times Cited: 71
Transcriptional regulation of the survivin gene
Romain Boidot, Frédérique Végran, Sarab Lizard‐Nacol
Molecular Biology Reports (2013) Vol. 41, Iss. 1, pp. 233-240
Closed Access | Times Cited: 69
Leflunomide: A promising drug with good antitumor potential
Chunying Zhang, Maolin Chu
Biochemical and Biophysical Research Communications (2018) Vol. 496, Iss. 2, pp. 726-730
Closed Access | Times Cited: 58
Elevated expression of JMJD6 is associated with oral carcinogenesis and maintains cancer stemness properties
Chang-Ryul Lee, Sung Hee Lee, Nicole Kristina Rigas, et al.
Carcinogenesis (2015) Vol. 37, Iss. 2, pp. 119-128
Open Access | Times Cited: 55
An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer
Xiang Ling, Wenjie Wu, Chuandong Fan, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 54
Orai1 promotes tumor progression by enhancing cancer stemness via NFAT signaling in oral/oropharyngeal squamous cell carcinoma
Sung Hee Lee, Nicole Kristina Rigas, Chang-Ryul Lee, et al.
Oncotarget (2016) Vol. 7, Iss. 28, pp. 43239-43255
Open Access | Times Cited: 50
Interleukin‐4 administration improves muscle function, adult myogenesis, and lifespan of colon carcinoma‐bearing mice
Domiziana Costamagna, Robin Duelen, Fabio Penna, et al.
Journal of Cachexia Sarcopenia and Muscle (2020) Vol. 11, Iss. 3, pp. 783-801
Open Access | Times Cited: 49
Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment
Miriam Gaggianesi, Simone Di Franco, Vincenzo Davide Pantina, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 34
Interleukin-4 and interleukin-13 increase NADPH oxidase 1-related proliferation of human colon cancer cells
Han Liu, Smitha Antony, Krishnendu Roy, et al.
Oncotarget (2017) Vol. 8, Iss. 24, pp. 38113-38135
Open Access | Times Cited: 46
Peripheral Innate Lymphoid Cells Are Increased in First Line Metastatic Colorectal Carcinoma Patients: A Negative Correlation With Th1 Immune Responses
Romain Loyon, Marine Jary, Bérengère Salomé, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 40
An Updated Review of Oral Cancer Stem Cells and Their Stemness Regulation
Kihyuk Shin, Reuben H. Kim
Critical Reviews™ in Oncogenesis (2018) Vol. 23, Iss. 3-4, pp. 189-200
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top